Peter Attia MD348 ‒ Women’s sexual health, menopause, and hormone replacement therapy (HRT)
At a glance
WHAT IT’S REALLY ABOUT
Rachel Rubin on Menopause, Hormone Therapy, Testosterone, and Medicine's Failures
- Rubin describes perimenopause as erratic hormone swings and menopause as an empty tank, with effects reaching bone, brain, joints, bladder, and genital tissue.
- Both speakers argue the Women's Health Initiative was misinterpreted, scared off an industry and a generation of prescribers, and left box labeling in place that Rubin says is unsupported.
- Rubin makes the case that testosterone is underused in women, and that vaginal estrogen or DHEA are cheap, safe options that she says cut UTI risk by more than half.
- The two compare practical prescribing approaches covering progesterone, transdermal versus oral estradiol, rings and patches, and lab testing with LC-MS assays.
- They address who should get therapy and for how long, including after menopause, beyond 10 years, and with BRCA, DCIS, or breast cancer history, and how women can find good providers and avoid dubious clinics.
IDEAS WORTH REMEMBERING
5 ideasPerimenopause is defined by erratic hormones, not simply low ones
Rubin says estradiol can swing from near zero to around 1,000 within a short time, and symptoms can come from levels that are too low, too high, or changing quickly. Her gas tank analogy frames menopause as an empty tank and perimenopause as overfilling and then draining.
The WHI findings were misread and the fear persists
Rubin says the trial tested one synthetic estrogen and progestin at one dose, with some benefits like fewer fractures and less colon cancer. Attia adds that the breast cancer increase was 0.1% in absolute terms with no added mortality.
A training gap may matter as much as the lost generation
Rubin cites data that fewer than 6% of internal medicine, OBGYN, or family practice doctors get even an hour of menopause training. She says prescribers who knew how to do this have retired or died without teaching successors.
Testosterone is a neglected third hormone in women
Rubin says testosterone declines from the 30s, that regular periods don't mean normal hormones, and that there is global consensus it helps low libido in postmenopausal women. She uses low-dose topical male gel and avoids pellets because of supraphysiologic levels.
Local vaginal hormones are high-value and widely underused
Rubin says low-dose vaginal estrogen or DHEA reduces UTI risk by more than half, is safe for essentially everyone, and costs about $13 a tube. She estimates universal use in Medicare-eligible women would save $6 to $22 billion a year.
WORDS WORTH SAVING
5 quotesThey misinterpreted the data so drastically and scared everybody with so much fear that you actually have an entire generation that has forgotten how to prescribe hormone therapy.
— Rachel Rubin
If a penis shriveled up at age 52, we'd probably have a vaccine sponsored by Pfizer, right?
— Rachel Rubin
We love to gaslight women and say, "Well, if you have your period, your hormones are normal." And the reality is, is that's not true.
— Rachel Rubin
The reality is this is half the population. This is not niche medicine.
— Rachel Rubin
We're killing women by trying to protect them.
— Rachel Rubin
High quality AI-generated summary created from speaker-labeled transcript.
